A Calcineurin-NFATc3-Dependent Pathway Regulates Skeletal Muscle Differentiation and Slow Myosin Heavy-Chain Expression

ABSTRACT The differentiation and maturation of skeletal muscle cells into functional fibers is coordinated largely by inductive signals which act through discrete intracellular signal transduction pathways. Recently, the calcium-activated phosphatase calcineurin (PP2B) and the family of transcription factors known as NFAT have been implicated in the regulation of myocyte hypertrophy and fiber type specificity. Here we present an analysis of the intracellular mechanisms which underlie myocyte differentiation and fiber type specificity due to an insulinlike growth factor 1 (IGF-1)–calcineurin–NFAT signal transduction pathway. We demonstrate that calcineurin enzymatic activity is transiently increased during the initiation of myogenic differentiation in cultured C2C12 cells and that this increase is associated with NFATc3 nuclear translocation. Adenovirus-mediated gene transfer of an activated calcineurin protein (AdCnA) potentiates C2C12 and Sol8 myocyte differentiation, while adenovirus-mediated gene transfer of noncompetitive calcineurin-inhibitory peptides (cain or ΔAKAP79) attenuates differentiation. AdCnA infection was also sufficient to rescue myocyte differentiation in an IGF-depleted myoblast cell line. Using 10T1/2 cells, we demonstrate that MyoD-directed myogenesis is dramatically enhanced by either calcineurin or NFATc3 cotransfection, while a calcineurin inhibitory peptide (cain) blocks differentiation. Enhanced myogenic differentiation directed by calcineurin, but not NFATc3, preferentially specifies slow myosin heavy-chain expression, while enhanced differentiation through mitogen-activated protein kinase kinase 6 (MKK6) promotes fast myosin heavy-chain expression. These data indicate that a signaling pathway involving IGF-calcineurin-NFATc3 enhances myogenic differentiation whereas calcineurin acts through other factors to promote the slow fiber type program.

[1]  E. Olson,et al.  Stimulation of Slow Skeletal Muscle Fiber Gene Expression by Calcineurin in Vivo * , 2000, The Journal of Biological Chemistry.

[2]  J. Molkentin,et al.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Schaloske,et al.  Ca2+/Calmodulin-independent Activation of Calcineurin from Dictyostelium by Unsaturated Long Chain Fatty Acids* , 1999, The Journal of Biological Chemistry.

[4]  R. Cooper,et al.  In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. , 1999, Journal of cell science.

[5]  Richard P. Harvey,et al.  Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway , 1999, Nature.

[6]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[7]  R. Michel,et al.  Calcineurin Is Required for Skeletal Muscle Hypertrophy* , 1999, The Journal of Biological Chemistry.

[8]  A. Rao,et al.  NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Wheeler,et al.  An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. , 1999, American journal of physiology. Cell physiology.

[10]  R. Graham,et al.  Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model. , 1999, The Biochemical journal.

[11]  A. Musarò,et al.  Maturation of the Myogenic Program Is Induced by Postmitotic Expression of Insulin-Like Growth Factor I , 1999, Molecular and Cellular Biology.

[12]  H. Westerblad,et al.  Insulin increases near-membrane but not global Ca2+ in isolated skeletal muscle. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Crabtree.  Generic Signals and Specific Outcomes Signaling through Ca2+, Calcineurin, and NF-AT , 1999, Cell.

[14]  E. Bengal,et al.  p38 Mitogen-activated Protein Kinase Pathway Promotes Skeletal Muscle Differentiation , 1999, The Journal of Biological Chemistry.

[15]  A. Musarò,et al.  Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Vogt,et al.  An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Ferrari,et al.  Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Pavlath,et al.  Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. , 1998, Molecular biology of the cell.

[19]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[20]  S. Snyder,et al.  Cain, A Novel Physiologic Protein Inhibitor of Calcineurin* , 1998, The Journal of Biological Chemistry.

[21]  M. White,et al.  A Role for RalGDS and a Novel Ras Effector in the Ras-mediated Inhibition of Skeletal Myogenesis* , 1998, The Journal of Biological Chemistry.

[22]  H. Youn,et al.  Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. , 1998, Immunity.

[23]  D. Ross,et al.  Cellular adaptations of skeletal muscles to cyclosporine. , 1998, Journal of applied physiology.

[24]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[25]  L. Kedes,et al.  Altered expression of tropomodulin in cardiomyocytes disrupts the sarcomeric structure of myofibrils. , 1998, Circulation research.

[26]  L. Scorrano,et al.  The mitochondrial permeability transition , 2022, BioFactors.

[27]  M. Palacín,et al.  Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. , 1998, Molecular endocrinology.

[28]  V. E. Pettorossi,et al.  Partial transformation from fast to slow muscle fibers induced by deafferentation of capsaicin‐sensitive muscle afferents , 1997, Muscle & nerve.

[29]  A. Joly,et al.  Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation , 1997, FEBS letters.

[30]  Christopher C. Goodnow,et al.  Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.

[31]  F. Stockdale,et al.  Mechanisms of formation of muscle fiber types. , 1997, Cell structure and function.

[32]  L. Kedes,et al.  Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.

[33]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[34]  H. Bernardi,et al.  Rabbit slow and fast skeletal muscle‐derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin‐like growth factor system , 1996, Journal of cellular physiology.

[35]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[36]  A. Kahn,et al.  Growth and differentiation of C2 myogenic cells are dependent on serum response factor , 1996, Molecular and cellular biology.

[37]  M. Kushmerick,et al.  Activity-dependent induction of slow myosin gene expression in isolated fast-twitch mouse muscle. , 1996, The American journal of physiology.

[38]  D. Livingston,et al.  Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. , 1996, Genes & development.

[39]  E. Olson,et al.  Defining the regulatory networks for muscle development. , 1996, Current opinion in genetics & development.

[40]  D. Pette,et al.  Fiber transformation and replacement in low-frequency stimulated rabbit fast-twitch muscles , 1996, Cell and Tissue Research.

[41]  C. Stewart,et al.  Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism , 1996, The Journal of cell biology.

[42]  G. Condorelli,et al.  Human p300 Protein Is a Coactivator for the Transcription Factor MyoD (*) , 1996, The Journal of Biological Chemistry.

[43]  K. Irie,et al.  Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2. , 1996, The Journal of biological chemistry.

[44]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[45]  K. Walsh,et al.  MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation , 1995, Molecular and cellular biology.

[46]  T. Hoey,et al.  Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. , 1995, Immunity.

[47]  K. Arai,et al.  NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus , 1995, Molecular and cellular biology.

[48]  A. Lassar,et al.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase , 1995, Science.

[49]  G. Nolan,et al.  NF-AT components define a family of transcription factors targeted in T-cell activation , 1994, Nature.

[50]  T. Wood,et al.  Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. , 1994, Endocrinology.

[51]  P. Rotwein,et al.  A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. , 1993, The Journal of biological chemistry.

[52]  N. Rosenthal,et al.  Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. , 1993, Endocrinology.

[53]  E. Olson,et al.  FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains , 1992, Cell.

[54]  C. Newgard,et al.  Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. , 1992, The Journal of biological chemistry.

[55]  D. Allen,et al.  Changes of myoplasmic calcium concentration during fatigue in single mouse muscle fibers , 1991, The Journal of general physiology.

[56]  P. Rotwein,et al.  Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. , 1989, The Journal of biological chemistry.

[57]  J. Changeux,et al.  Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Gergely,et al.  Changes in intracellular ionized Ca concentration associated with muscle fiber type transformation. , 1987, The American journal of physiology.

[59]  S. Salmons,et al.  Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. , 1986, The Journal of biological chemistry.

[60]  Helen M. Blau,et al.  Cytoplasmic activation of human nuclear genes in stable heterocaryons , 1983, Cell.